Karen Lewis - 13 Jan 2025 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief People Officer
Signature
/s/ David Watson, attorney-in-fact for Karen Lewis
Issuer symbol
APLS
Transactions as of
13 Jan 2025
Net transactions value
-$45,895
Form type
4
Filing time
14 Jan 2025, 16:20:14 UTC
Previous filing
31 Jan 2024
Next filing
21 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $45,895 -1,599 -3.4% $28.70 45,099 13 Jan 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 10, 2025.
F2 This includes 116 shares from April 30, 2024 ESPP purchase and 195 shares from the October 31, 2024 ESPP purchase.